Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM
6.09
-0.41%
After-hours: Aug 15, 2025, 07:47 PM EDT

Solid Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-39.48M -39.28M -42.6M -32.73M -25.07M -24.3M -20.34M -20.98M -24.63M -30.07M -15.15M -20.41M -25.09M -25.33M -18.61M -17.98M -18.7M -16.9M
Depreciation & Amortization
-488K 407K 488K 405K 1.24M 327K 587K 588K 703K 1.08M 539K 438K 722K 709K 760K 751K 719K 734K
Stock-Based Compensation
3.15M 3.34M 3.82M 3M 2.09M 1.61M 1.94M 1.63M 1.94M 2.12M 1.59M 1.52M 1.81M 2.61M 3.42M 3.42M 3.63M 2.91M
Other Working Capital
-2.54M 1.33M 1.31M 1.92M -990K -1.6M -2M 2.15M -2.71M -2.75M 2.85M -2.25M 6.46M -5.72M -3.04M -3.23M -3.31M -3.06M
Other Non-Cash Items
1.95M 1.89M 6.51M 2.78M 200K -634K 1.83M 19.36M 22.68M -215K -18.51M -17K -94K 371K 584K 534K 7K 3K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.98M -20.34M -22.74M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-2.54M 1.79M 2.13M 2.84M 78K -2.19M -1.86M 1.85M -5.42M -905K -2.94M -1.96M 6.77M -5.55M -7.02M -5.14M -2.77M -8.11M
Operating Cash Flow
-37.41M -31.85M -29.64M -23.71M -21.47M -25.19M -20.82M -17.9M -27.46M -28M -34.48M -20.43M -15.88M -27.19M -20.87M -18.42M -17.1M -21.37M
Capital Expenditures
-377K -126K -204K -15K -286K -149K -90K -383K -536K -506K -856K -839K -1.14M -184K -660K -237K -349K -35K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -45.39M 24.25M 47.7M n/a 31.52M 600K 58.46M n/a n/a n/a n/a n/a
Purchase of Investments
-63.44M -65.34M -15.33M -85.47M -20.19M -83.35M -14.61M -34.25M -68.56M n/a -19.61M -50.46M -103.81M -8.88M -16.68M -76.2M -48.37M n/a
Sales Maturities Of Investments
31M 38M 54.1M 74.5M 15.3M 45M 60M 10M 20.87M 37.77M 55.05M 65.61M 45.35M 46.81M 47.51M 3.93M n/a n/a
Other Investing Acitivies
85K n/a n/a n/a n/a 5K 45.39M -24.25M -47.7M 37.77M 35.43M 15.75M -58.46M 37.93M 30.84M -72.27M -48.37M n/a
Investing Cash Flow
-32.73M -27.46M 38.57M -10.99M -5.18M -38.49M 45.3M -24.64M -48.23M 37.26M 66.1M 14.91M -59.59M 37.74M 30.18M -72.51M -48.72M -35K
Debt Repayment
-142K -135K -128K -120K -225K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a 78K n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
196K n/a 122.49M 5.39M -141K -4.83M 70K n/a 78K n/a 2.19M -1K 73K 22K 66K 3K 9K 29K
Financial Cash Flow
-1.6M 189.73M 6.94M 3.26M 5M 107.24M 505K n/a 2.62M n/a 74.74M -1K 73K 22K 66K 3K -238K 135.15M
Net Cash Flow
-71.75M 130.41M 15.86M -31.44M -21.72M 43.56M 24.98M -42.53M -73.08M 9.27M 106.36M -5.52M -75.4M 10.57M 9.37M -90.93M -66.06M 113.75M
Free Cash Flow
-37.79M -31.98M -29.85M -23.72M -21.75M -25.34M -20.91M -18.28M -28M -28.5M -35.34M -21.27M -17.01M -27.37M -21.53M -18.66M -17.45M -21.4M